Gyre Therapeutics Inc (GYRE)
14.15
-1.14
(-7.46%)
USD |
NASDAQ |
May 17, 16:00
14.15
0.00 (0.00%)
After-Hours: 20:00
Gyre Therapeutics Total Assets (Quarterly): 122.01M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 122.01M |
Date | Value |
---|---|
March 31, 2023 | 110.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
110.17M
Minimum
Mar 2023
122.01M
Maximum
Mar 2024
116.09M
Average
116.09M
Median
Total Assets (Quarterly) Benchmarks
CEL-SCI Corp | 30.05M |
AIM ImmunoTech Inc | 19.38M |
IGC Pharma Inc | 11.26M |
NovaBay Pharmaceuticals Inc | 5.357M |
Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 33.24M |
Shareholders Equity (Quarterly) | 56.64M |
Current Ratio | 3.219 |